NCT07326488 2026-04-13
A Study of MHB009C in Patients With Advanced Solid Tumors
Minghui Pharmaceutical (Hangzhou) Ltd
Phase 1/2 Recruiting
Minghui Pharmaceutical (Hangzhou) Ltd
Minghui Pharmaceutical (Hangzhou) Ltd
Virogin Biotech Ltd.
National Cancer Institute, Naples
Repertoire Immune Medicines
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
BioNTech SE
Minghui Pharmaceutical (Hangzhou) Ltd
Sinocelltech Ltd.
Sinocelltech Ltd.
Minghui Pharmaceutical (Hangzhou) Ltd